Ivax receives approval for generic Pletal and Econ labs announces Q4 results.

0 Comments | M2 Presswire, March, 2005

M2 PRESSWIRE-2 March 2005-FNWU: Ivax receives approval for generic Pletal and Econ labs announces Q4 results(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:02032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Ivax Corp. (Nasdaq: IVX) said the U.S.

Food and Drug Administration approved its filing to market 100 mg tablets of cilostazol, a generic form of Pletal that is used to treat pain in the legs that happens when walking. Eon Labs, Inc. (Nasdaq: ELAB) recently reported net income of $30.2 million for the fourth quarter ended December 31, 2004, compared to $19.2 million in the comparable quarter in 2003, an increase of 57.3. For the year ended December 31, 2004, net income was $119.4 million, compared to $70.1...